European Archives - Page 542 of 1162 - European Medical Journal

Infographic: Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia is rare cancer of the blood cells. This infographic provides an overview of this pathology, outlining epidemiology, symptoms, treatment options, and prognosis.

Are Positive Urine Cultures Directly Correlated with Elevated Levels of Novel Biomarkers for Childhood Urinary Tract Infection?

Urinary tract infection (UTI) in children is one of the most common bacterial infections that propels inappropriate antibiotic use…

Molecular Characterisation of Diarrhoeagenic Escherichia coli Isolated from Captive and Free-Ranging Olive Baboons (Papio anubis) Faecal Samples

Escherichia coli is a normal inhabitant of the mammalian gut, but it also exists in a number of pathogenic forms. Diarrhoeagenic E. coli…

Behind the hype of ChatGPT

Now that the world has had time to see the risks and rewards of ChatGPT, pharma industry must decide whether to take it or leave it. Read for more.

Could Topical Antifungals Result in Foot Dermatitis?

Recent research has shown that foot antifungals prescribed for infections could be a causing factor of foot dermatitis…

Beneath the Surface of Teledermatology

This week, Jonathan is joined by Paola Pasquali, established dermatologist with particular expertise in cryosurgery and non-invasive imaging

New Literature Improving Clinical Understanding of Retronychia

Novel insights into retronychia have provided clinical clarity for healthcare professionals, allowing accurate diagnosis of the condition…

Improving R&D pipeline projections

This infographic examines how the pharmaceutical industry’s R&D pipeline is evolving, looking at the companies leading the way and factors behind the recent uptick in IRR.

Facial Swelling as a Presenting Sign of Cholangiocarcinoma

Cholangiocarcinoma is a malignancy of the intrahepatic or extrahepatic (perihilar or distal) biliary tree, forming less than 2% of all…

Pharma in China, untapped markets and drug development

In this episode, Marc and Helena talk China with Novartis’ Isabel Afonso and drug development with Farid Khan, CEO of PharmaKure. Listen now!